Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pelvic exenteration].

D Cibula1, P Freitag, D Ficherová

  • 1Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha.

Ceska Gynekologie
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Patients' Symptoms and Support Needs at Start of Specialized Palliative Care Therapy in an Inpatient Oncology Setting. A Retrospective Data Analysis.

The American journal of hospice & palliative care·2026
Same author

Comparison of ultrasound with computed tomography and whole-body diffusion-weighted MRI in prediction of surgical outcome using ESMO-ESGO criteria in patients with tubo-ovarian carcinoma: prospective ISAAC study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

The role of HPV testing in the follow-up of patients in different clinical scenarios after diagnosis of cervical preinvasive lesions and carcinomas.

Expert review of anticancer therapy·2025
Same author

Practical recommendations for the use of PARP inhibitors in the treatment of ovarian cancer.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Dostarlimab and niraparib in primary advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same journal

ESGO/ISUOG guidelines for needle biopsies in gynecologic oncology - the adapted version.

Ceska gynekologie·2026
Same journal

Impact of selected dimensions of pelvic floor structures on the process of delivery - a review of the literature.

Ceska gynekologie·2026
Same journal

Limits of preeclampsia screening and prevention in a population of women after assisted reproductive technologies.

Ceska gynekologie·2026
Same journal

Clinically relevant histopathological features and biomarkers in endometrial cancer.

Ceska gynekologie·2026
Same journal

Vulvodynia and persistent vulvar pain - diagnosis, treatment, and the role of laser vaporization.

Ceska gynekologie·2026
Same journal

Endometrioma of Bartholin's gland.

Ceska gynekologie·2026
See all related articles

Pelvic exenteration surgery offers a vital treatment option for advanced gynecologic cancers when other therapies fail. Despite significant risks, this procedure improves survival rates for patients with recurrent or primary tumors.

Area of Science:

  • Oncologic surgery
  • Gynecologic oncology
  • Surgical oncology

Context:

  • Pelvic exenteration is a complex surgical procedure indicated for advanced or recurrent gynecologic malignancies.
  • Indications primarily include advanced cervical, vulva, or vaginal cancers, and occasionally locally advanced primary tumors.
  • This review critically assesses published data on pelvic exenterative procedures.

Purpose:

  • To review the existing literature on pelvic exenterative procedures.
  • To evaluate the indications, outcomes, and challenges associated with pelvic exenteration.
  • To provide a critical assessment of the role of exenterative procedures in oncogynecology.

Summary:

  • Pelvic exenterations are crucial in oncogynecology for specific indications, particularly recurrent or advanced cervical, vulva, and vaginal cancers.

Related Experiment Videos

  • While associated with significant morbidity (40-60%) and mortality (5-10%), these procedures offer a survival benefit, with 5-year survival rates around 50-60%.
  • Preoperative staging with explorative laparoscopy helps minimize non-therapeutic surgeries, and the procedure is justified by improved survival compared to no treatment (median survival of 6 months).

    • Impact:

    • Pelvic exenteration provides a life-saving option for patients with otherwise untreatable gynecologic cancers.
    • Despite high morbidity, the procedure significantly improves long-term survival, offering a chance for cure or prolonged life.
    • Advancements in preoperative staging aim to optimize patient selection and reduce surgical complications, enhancing the overall success of exenterative procedures.